Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Eur J Med Genet ; 59(8): 396-400, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27373676

ABSTRACT

Genetic factor plays an important role in cardiac arrhythmias. Several loci have been identified associated with this disease. However, they only explained parts of it and more genes and loci remain to be identified. In present study, we recruited a four generation family from the north of China. Four members of this family were diagnosed with atrial fibrillation by electrocardiogram (ECG). We used Exome Sequencing and Sanger sequencing to explore the candidate mutation for cardiac arrhythmia in this family. A nonsense mutation (c.G1494A, p.Trp498Ter) in the LMNA gene were identified as the candidate mutation. This variant is a novel mutation and has not yet been reported for any actual databases. This novel mutation co-segregated exactly with the disease in this family. Meanwhile, it was not detected in 524 control subjects of matched ancestry. According to structural model prediction, the mutation is expected to affect the Lamin Tail Domain (LTD) of lamin A/C protein. So the nonsense mutation discovered in the family probably was a novel mutation associated with familial atrial fibrillation. This discovery expands the mutation spectrum of LMNA and indicates the importance of LMNA in AF.


Subject(s)
Atrial Fibrillation/diagnosis , Atrial Fibrillation/genetics , Codon, Nonsense , Lamin Type A/genetics , Amino Acid Sequence , Computational Biology/methods , DNA Mutational Analysis , Electrocardiography , Exome , Family , Female , Genetic Association Studies , High-Throughput Nucleotide Sequencing , Humans , Lamin Type A/chemistry , Male , Models, Molecular , Pedigree , Protein Conformation , Structure-Activity Relationship
2.
Medicine (Baltimore) ; 95(15): e3323, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27082579

ABSTRACT

Mitochondrial DNA (mtDNA) copy number variation (CNV), which reflects the oxidant-induced cell damage, has been observed in a wide range of human diseases. However, whether it correlates with heart failure, which is closely related to oxidative stress, has never been elucidated before. We aimed to systematically investigate the associations between leukocyte mtDNA CNV and heart failure risk and prognosis. A total of 1700 hospitalized patients with heart failure and 1700 age- and sex-matched community population were consecutively enrolled in this observational study, as well as 1638 (96.4%) patients were followed prospectively for a median of 17 months (12-24 months). The relative mtDNA copy number of leukocyte of peripheral blood or cardiac tissue was measured in triplicate by quantitative real-time PCR method. Patients with heart failure possessed much lower relative mtDNA copy number compared with control subjects (median 0.83, interquartile range [IQR] 0.60-1.16 vs median 1.00, IQR 0.47-2.20; P < 0.001), especially for the patients with ischemic etiology (median, 0.77 for ischemic and 0.91 for non-ischemic, P < 0.001). Patients with lower mtDNA copy number exhibited 1.7 times higher risk of heart failure (odds ratio 1.71, 95% confidence interval [CI] 1.48-1.97, P < 0.001). Long-term follow-up (median of 17 months) showed that decreased mtDNA copy number was significant associated with both increased cardiovascular deaths (hazard ratio [HR] 1.58, 95% CI 1.16-2.16, P = 0.004) and cardiovascular rehospitalization (HR 1.48, 95% CI 1.21-1.82, P < 0.001). After adjusting for the conventional risk factors and medications, lower mtDNA copy numbers were still significantly associated with 50% higher cardiovascular mortality (P = 0.035). In conclusion, mtDNA copy number depletion is an independent risk factor for heart failure and predicts higher cardiovascular mortality in patients with heart failure.


Subject(s)
DNA Copy Number Variations , DNA, Mitochondrial/analysis , Heart Failure , Leukocytes/metabolism , Aged , Case-Control Studies , China , Female , Heart Failure/blood , Heart Failure/diagnosis , Heart Failure/genetics , Heart Failure/mortality , Humans , Male , Middle Aged , Odds Ratio , Oxidative Stress , Prognosis , Proportional Hazards Models , Risk Factors
3.
Heart Rhythm ; 13(7): 1515-20, 2016 07.
Article in English | MEDLINE | ID: mdl-27033637

ABSTRACT

BACKGROUND: In Brugada syndrome (BrS), spontaneous type 1 electrocardiogram (ECG) is an established risk marker for fatal arrhythmias whereas drug-induced type 1 ECG shows a relatively benign prognosis. No study has analyzed the prognosis of fever-induced type 1 ECG (F-type1) in a large BrS cohort. OBJECTIVES: The objectives of this study were to assess the prognosis of F-type1 in asymptomatic BrS and to compare the effects of fever and drugs on ECG parameters. METHODS: One hundred twelve patients with BrS who developed F-type1 were retrospectively enrolled. Prognosis was evaluated in 88 asymptomatic patients. In a subgroup (n = 52), ECG parameters of multiple ECGs (at baseline, during fever, and after drug challenge) were analyzed. RESULTS: Eighty-eight asymptomatic patients had a mean age of 45.8 ± 18.7 years, and 71.6% (67 of 88) were men. Twenty-one percent (18 of 88) had a family history of sudden cardiac death, and 26.4% (14 of 53) carried a pathogenic SCN5A mutation. Drug challenge was positive in 29 of 36 patients tested (80.6%). The risk of ventricular fibrillation in asymptomatic patients was 0.9%/y (3 of 88; 43.6 ± 37.4 months). ST-segment elevation in lead V2 during fever and after drug challenge was not significantly different (0.41 ± 0.21 ms during fever and 0.40 ± 0.30 ms after drug challenge; P > .05). Fever shortened the PR interval compared to baseline, whereas drug challenge resulted in prolonged PR interval and QRS duration (PR interval: 169 ± 29 ms at baseline, 148 ± 45 ms during fever, and 202 ± 35 ms after drug challenge; QRS duration: 97 ± 18 ms at baseline, 92 ± 28 ms during fever, and 117 ± 21 ms after drug challenge). CONCLUSION: Patients with BrS who develop F-type1 are at risk of arrhythmic events. F-type1 appears to develop through a more complex mechanism as compared with drug-induced type 1 ECG.


Subject(s)
Brugada Syndrome , Electrocardiography/methods , Fever/complications , Heart Conduction System , Sodium Channel Blockers/adverse effects , Ventricular Fibrillation , Adult , Asymptomatic Diseases , Brugada Syndrome/diagnosis , Brugada Syndrome/physiopathology , Female , Heart Conduction System/drug effects , Heart Conduction System/physiopathology , Humans , Male , Middle Aged , Outpatients , Prognosis , Retrospective Studies , Risk Assessment , Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/etiology , Ventricular Fibrillation/physiopathology
4.
Int J Clin Exp Med ; 8(4): 5485-91, 2015.
Article in English | MEDLINE | ID: mdl-26131127

ABSTRACT

The involvement of the AGC protein kinase family in regulating arrhythmia has drawn considerable attention, but the underlying mechanisms are still not clear. The aim of this study is to explore the role of 3-phosphoinositide-dependent protein kinase-1 (PDK1), one of upstream protein kinases of the AGC protein kinase family, in the pathogenesis of dysregulated electrophysiological basis. PDK1(F/F) αMHC-Cre mice and PDK1(F/F) mice were divided into experiment group and control group. Using patch clamping technology, we explored action potential duration in both groups, and investigated the functions of transient outward potassium channel and L-type Ca(2+) channel to explain the abnormal action potential duration. Significant prolongation action potential duration was found in mice with PDK1 deletion. Further, the peak current of transient outward potassium current and L-type Ca(2+) current were decreased by 84% and 49% respectively. In addition, dysregulation of channel kinetics lead to action potential duration prolongation further. In conclusion, we have demonstrated that PDK1 participates in action potential prolongation in cardiac ablation of PDK1 mice. This effect is likely to be mediated largely through downregulation of transient outward potassium current. These findings indicate the modulation of the PDK1 pathway could provide a new mechanism for abnormal electrophysiological basis.

5.
PLoS One ; 10(3): e0122436, 2015.
Article in English | MEDLINE | ID: mdl-25781322

ABSTRACT

BACKGROUND: The AGC protein kinase family regulates multiple cellular functions. 3-phosphoinositide-dependent protein kinase-1 (PDK1) is involved in the pathogenesis of arrhythmia, and its downstream factor, Forkhead box O1 (Foxo1), negatively regulates the expression of the cardiac sodium channel, Nav1.5. Mice are known to die suddenly after PDK1 deletion within 11 weeks, but the underlying electrophysiological bases are unclear. Thus, the aim of this study was to investigate the potential mechanisms between PDK1 signaling pathway and cardiac sodium current. METHODS AND RESULTS: Using patch clamp and western blotting techniques, we investigated the role of the PDK1-Foxo1 pathway in PDK1 knockout mice and cultured cardiomyocytes. We found that PDK1 knockout mice undergo slower heart rate, prolonged QRS and QTc intervals and abnormal conduction within the first few weeks of birth. Furthermore, the peak sodium current is decreased by 33% in cells lacking PDK1. The phosphorylation of Akt (308T) and Foxo1 (24T) and the expression of Nav1.5 in the myocardium of PDK1-knockout mice are decreased, while the nuclear localization of Foxo1 is increased. The role of the PDK1-Foxo1 pathway in regulating Nav1.5 levels and sodium current density was verified using selective PDK1, Akt and Foxo1 inhibitors and isolated neonatal rat cardiomyocytes. CONCLUSION: These results indicate that PDK1 participates in the dysregulation of electrophysiological basis by regulating the PDK1-Foxo1 pathway, which in turn regulates the expression of Nav1.5 and cardiac sodium channel function.


Subject(s)
Myocardium/metabolism , Myocytes, Cardiac/metabolism , NAV1.5 Voltage-Gated Sodium Channel/metabolism , Protein Serine-Threonine Kinases/metabolism , Sodium/metabolism , Animals , Forkhead Box Protein O1 , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/metabolism , Gene Deletion , Ion Transport/physiology , Mice , Mice, Knockout , NAV1.5 Voltage-Gated Sodium Channel/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Protein Serine-Threonine Kinases/genetics , Pyruvate Dehydrogenase Acetyl-Transferring Kinase , Rats , Rats, Sprague-Dawley
6.
Eur J Med Genet ; 58(4): 258-65, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25765472

ABSTRACT

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiomyopathy that primarily involves the right ventricle. Mutations in desmosomal genes have been associated with ARVC. But its prevalence and spectrum are much less defined in the Chinese population, especially Han Chinese, a majority ethnic group in China; also the genotype-phenotype correlation regarding left ventricular involvement is still poorly understood. The aim of this study was to elucidate the genotype in Han Chinese patients with ARVC and the phenotype regarding cardiac left ventricle involvement in mutation carriers of ARVC. 48 Han Chinese patients were recruited into the present study based on the Original International Task Force Criteria of ARVC. Clinical data were reassessed according to the modified criteria published in 2010. A total of 36 subjects were diagnosed with ARVC; 12 patients were diagnosed with suspected ARVC. Five desmosomal genes (PKP2, DSG2, DSP, DSC2 and JUP) were sequenced directly from genomic DNA. Among the 36 patients, 21 mutations, 12 of which novel, were discovered in 19 individuals (19 of 36, 53%). The distribution of the mutations was 25% in PKP2, 14% in DSP, 11% in DSG2, 6% in JUP, and 3% in DSC2. Multiple mutations were identified in 2 subjects (2 of 36, 6%); both had digenic heterozygosity. Eight mutations, of which six were novel, were located in highly conserved regions. Seven mutations introduced a stop codon prematurely, which would result in premature termination of the protein synthesis. Two-dimensional echocardiography showed that LDVd and LDVs parameters were significantly larger in nonsense mutation carriers than in carriers of other mutations. In this comprehensive desmosome genetic analysis, 21 mutations were identified in five desmosomal genes in a group of 48 local Han Chinese subjects with ARVC, 12 of which were novel. PKP2 mutations were the most common variants. Left ventricular involvement could be a sign that the patient is a carrier of a nonsense cardiac desmosomal gene mutation.


Subject(s)
Arrhythmias, Cardiac/genetics , Arrhythmogenic Right Ventricular Dysplasia/genetics , Desmosomes/genetics , Heart Ventricles/pathology , Adult , Arrhythmias, Cardiac/pathology , Arrhythmogenic Right Ventricular Dysplasia/mortality , Asian People/genetics , Base Sequence , China , Codon, Nonsense/genetics , DNA Mutational Analysis , Echocardiography , Ethnicity/genetics , Female , Genetic Association Studies , Genetic Predisposition to Disease , Genetic Testing , Humans , Male , Middle Aged , Plakophilins/genetics
7.
PLoS One ; 10(2): e0117567, 2015.
Article in English | MEDLINE | ID: mdl-25689866

ABSTRACT

BACKGROUND AND OBJECT: Cell apoptosis is a contributing factor in the initiation, progression and relapse of atrial fibrillation (AF), a life-threatening illness accompanied with stroke and heart failure. However, the regulatory cascade of apoptosis is intricate and remains unidentified, especially in the setting of AF. The aim of this study was to explore the roles of endoplasmic reticulum (ER) stress, mitochondrial apoptotic pathway (MAP), mitogen-activated protein kinases (MAPKs), and their cross-talking in tachypacing-induced apoptosis. METHODS AND RESULTS: HL-1 cells were cultured in the presence of tachypacing for 24 h to simulate atrial tachycardia remodeling. Results showed that tachypacing reduced cell viability measured by the cell counting kit-8, dissipated mitochondrial membrane potential detected by JC-1 staining and resulted in approximately 50% apoptosis examined by Hoechst staining and annexin V/propidium iodide staining. In addition, the proteins involved in ER stress, MAP and MAPKs were universally up-regulated or activated via phosphorylation, as confirmed by western blotting; and reversely silencing of ER stress, caspase-3 (the ultimate executor of MAP) and MAPKs with specific inhibitors prior to pacing partially alleviated apoptosis. An inhibitor of ER stress was applied to further investigate the responses of mitochondria and MAPKs to ER stress, and results indicated that suppression of ER stress comprehensively but incompletely attenuated the activation of MAP and MAPKs aroused by tachypacing, with the exception of ERK1/2, one branch of MAPKs. CONCLUSIONS: Our study suggested tachypacing-induced apoptosis is regulated by ER stress-mediated MAP and MAPKs. Thus, the above three components are all promising anti-apoptotic targets in AF patients and ER stress appears to play a dominant role due to its comprehensive effects.


Subject(s)
Apoptosis , Endoplasmic Reticulum Stress , Heart Atria/pathology , Mitochondria/pathology , Mitogen-Activated Protein Kinases/metabolism , Myocytes, Cardiac/pathology , Tachycardia/pathology , Animals , Atrial Remodeling , Cell Line, Tumor , Cell Survival , MAP Kinase Signaling System , Mice , Tachycardia/physiopathology , Time Factors
8.
Eur J Pharmacol ; 754: 52-60, 2015 May 05.
Article in English | MEDLINE | ID: mdl-25701724

ABSTRACT

A-803467 is a selective Nav1.8 blocker, but its mechanism of action at cardiac sodium channels is uncertain. Thus, we investigated the mechanistic effects of A-803467 on cardiac sodium channels in isolated mouse ventricular myocytes and in human embryonic kidney 293 (HEK293) cell lines that transiently expressed Nav1.5/SCN5A, the predominant cardiac sodium channel. At 0.3µM and greater, A-803467 blocked cardiac sodium currents in a dose-dependent manner in both ventricular myocytes and in SCN5A-expressing HEK293 cell lines. In both models, the drug caused significant depolarizing shifts at the conductance voltage relationship midpoint, hyperpolarizing shifts in voltage-dependent channel inactivation, and slower recovery from inactivation. Also, the drug reduced sodium current amplitude in a frequency-dependent manner, and blocked late sodium currents, accelerated inactivation, and enhanced the intermediate inactivation state. Our results provide strong evidence that A-803467 affects multiple biophysical characteristics of the canonical cardiac Nav1.5 channel and our data can be used to study potential applications of A-803467 as an antiarrhythmic drug.


Subject(s)
Aniline Compounds/pharmacology , Furans/pharmacology , Membrane Potentials/drug effects , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , NAV1.5 Voltage-Gated Sodium Channel/metabolism , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Electric Conductivity , HEK293 Cells , Humans , Ion Channel Gating/drug effects , Membrane Potentials/physiology , Mice , Sodium Channel Blockers/pharmacology
9.
Biochem Biophys Res Commun ; 449(3): 278-83, 2014 Jul 04.
Article in English | MEDLINE | ID: mdl-24857987

ABSTRACT

Atrial fibrillation (AF) is progressive and is the most common clinical arrhythmia. It is associated with inflammatory changes characterized by signal transducer and activator of transcription 3 (STAT3) signaling. A zinc finger homeobox 3 (ZFHX3, also named AT-motif binding factor 1, ATBF1) gene variant has been found in patients with AF. However, the mechanism by which the ATBF1 leads to inflammation in AF remains unknown. The aim of this study was to investigate whether tachypacing induces a decrease in ATBF1 expression and then activates STAT3 signaling via protein inhibitor of activated STAT3 (PIAS3). Atrial (HL-1 myocytes) cells were cultured in the presence of rapid electrical stimulations. In tachypaced HL-1 cells, we found that ATBF1 and PIAS3 protein levels were decreased, while the level of phosphorylated STAT3 (p-STAT3) was highly up-regulated compared with that of total STAT3. Knockdown of ATBF1 enhanced this trend, while the overexpression of ATBF1 had the opposite effect. A binary complex of ATBF1 and PIAS3 was formed and then the DNA-binding ability of activated STAT3 was enhanced in tachypaced HL-1 cells. These data indicate that tachypacing decreased ATBF1, leading to enhanced STAT3 DNA-binding activity due to the reduced formation of a binary complex of ATBF1 and PIAS3.


Subject(s)
Atrial Fibrillation/physiopathology , Homeodomain Proteins/metabolism , Myocytes, Cardiac/physiology , Protein Inhibitors of Activated STAT/metabolism , STAT3 Transcription Factor/metabolism , Animals , Atrial Fibrillation/metabolism , Cell Line , DNA/metabolism , Down-Regulation , Electric Stimulation , Gene Knockdown Techniques , Heart Atria/cytology , Homeodomain Proteins/genetics , Inflammation/metabolism , Mice , Myocytes, Cardiac/metabolism , RNA, Small Interfering/genetics , Signal Transduction , Transfection
11.
Am J Physiol Heart Circ Physiol ; 302(3): H782-9, 2012 Feb 01.
Article in English | MEDLINE | ID: mdl-22101522

ABSTRACT

Na(+) current derived from expression of the cardiac isoform SCN5A is reduced by receptor-mediated or direct activation of protein kinase C (PKC). Previous work has suggested a possible role for loss of Na(+) channels at the plasma membrane in this effect, but the results are controversial. In this study, we tested the hypothesis that PKC activation acutely modulates the intracellular distribution of SCN5A channels and that this effect can be visualized in living cells. In human embryonic kidney cells that stably expressed SCN5A with green fluorescent protein (GFP) fused to the channel COOH-terminus (SCN5A-GFP), Na(+) currents were suppressed by an exposure to PKC activation. Using confocal microscopy, colocalization of SCN5A-GFP channels with the plasma membrane under control and stimulated conditions was quantified. A separate population of SCN5A channels containing an extracellular epitope was immunolabeled to permit temporally stable labeling of the plasma membrane. Our results demonstrated that Na(+) channels were preferentially trafficked away from the plasma membrane by PKC activation, with a major contribution by Ca(2+)-sensitive or conventional PKC isoforms, whereas stimulation of protein kinase A (PKA) had the opposite effect. Removal of the conserved PKC site Ser(1503) or exposure to the NADPH oxidase inhibitor apocynin eliminated the PKC-mediated effect to alter channel trafficking, indicating that both channel phosphorylation and ROS were required. Experiments using fluorescence recovery after photobleaching demonstrated that both PKC and PKA also modified channel mobility in a manner consistent with the dynamics of channel distribution. These results demonstrate that the activation of protein kinases can acutely regulate the intracellular distribution and molecular mobility of cardiac Na(+) channels in living cells.


Subject(s)
Myocardium/enzymology , Protein Kinase C/metabolism , Protein Transport/physiology , Sodium Channels/metabolism , Calcium/metabolism , Cell Membrane/enzymology , Cyclic AMP-Dependent Protein Kinases/metabolism , Enzyme Activation/physiology , Green Fluorescent Proteins/genetics , HEK293 Cells , Humans , Membrane Potentials/physiology , Myocardial Contraction/physiology , NAV1.5 Voltage-Gated Sodium Channel , Sodium Channels/genetics
12.
J Cardiovasc Pharmacol ; 59(3): 249-53, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22030895

ABSTRACT

Beta-adrenergic receptor antagonists (ß-blockers) are the therapy of choice for the long QT syndrome but their efficacy is not homogeneous: propranolol and nadolol are the most effective, whereas metoprolol is associated with more treatment failures. Propranolol has a blocking effect on the sodium current ("membrane-stabilizing" effect), and it has been hypothesized that the efficacy of nadolol might be due to a similar effect. Accordingly, we used whole-cell patch-clamp recording to assess propranolol, nadolol, and metoprolol block of wild-type or mutant cardiac sodium channels (Nav1.5) coexpressed with ß1 subunit in tsA201 cells. Nadolol had a ∼20% non-use-dependent blocking effect on peak sodium current and no effect on the persistent current evoked by the LQT3 mutant A1330D, whereas propranolol blocked Nav1.5 in a use-dependent manner and reduced A1330D persistent current. Metoprolol had no effect on either the peak or persistent current. Analysis of the biophysical properties of the channel revealed that both nadolol and propranolol cause hyperpolarizing shifts on voltage dependence of activation and steady-state inactivation, whereas metoprolol shifts only the activation curve. These results provide partial explanation for the differences between nadolol and metoprolol but do not explain the similar clinical efficacy of nadolol and propranolol.


Subject(s)
Metoprolol/pharmacology , Nadolol/pharmacology , Propranolol/pharmacology , Sodium Channels/drug effects , Adrenergic beta-Antagonists/pharmacology , Cell Line , Humans , Long QT Syndrome/drug therapy , Mutation , NAV1.5 Voltage-Gated Sodium Channel , Patch-Clamp Techniques , Sodium Channel Blockers/pharmacology , Sodium Channels/metabolism
13.
Circulation ; 124(9): 1001-11, 2011 Aug 30.
Article in English | MEDLINE | ID: mdl-21824921

ABSTRACT

BACKGROUND: The D1275N SCN5A mutation has been associated with a range of unusual phenotypes, including conduction disease and dilated cardiomyopathy, as well as atrial and ventricular tachyarrhythmias. However, when D1275N is studied in heterologous expression systems, most studies show near-normal sodium channel function. Thus, the relationship of the variant to the clinical phenotypes remains uncertain. METHODS AND RESULTS: We identified D1275N in a patient with atrial flutter, atrial standstill, conduction disease, and sinus node dysfunction. There was no major difference in biophysical properties between wild-type and D1275N channels expressed in Chinese hamster ovary cells or tsA201 cells in the absence or presence of ß1 subunits. To determine D1275N function in vivo, the Scn5a locus was modified to knock out the mouse gene, and the full-length wild-type (H) or D1275N (DN) human SCN5A cDNAs were then inserted at the modified locus by recombinase mediated cassette exchange. Mice carrying the DN allele displayed slow conduction, heart block, atrial fibrillation, ventricular tachycardia, and a dilated cardiomyopathy phenotype, with no significant fibrosis or myocyte disarray on histological examination. The DN allele conferred gene-dose-dependent increases in SCN5A mRNA abundance but reduced sodium channel protein abundance and peak sodium current amplitudes (H/H, 41.0±2.9 pA/pF at -30 mV; DN/H, 19.2±3.1 pA/pF, P<0.001 vs. H/H; DN/DN, 9.3±1.1 pA/pF, P<0.001 versus H/H). CONCLUSIONS: Although D1275N produces near-normal currents in multiple heterologous expression experiments, our data establish this variant as a pathological mutation that generates conduction slowing, arrhythmias, and a dilated cardiomyopathy phenotype by reducing cardiac sodium current.


Subject(s)
Atrial Flutter/genetics , Cardiomyopathy, Dilated/genetics , Mutation, Missense , Sick Sinus Syndrome/genetics , Sodium Channels/genetics , Animals , Atrial Flutter/therapy , CHO Cells , Cricetinae , Cricetulus , Defibrillators, Implantable , Electrocardiography , Humans , Male , Mice , Mice, Transgenic , Myocardial Contraction/genetics , NAV1.5 Voltage-Gated Sodium Channel , Sick Sinus Syndrome/therapy , Treatment Outcome , Young Adult
14.
Front Pharmacol ; 1: 144, 2010.
Article in English | MEDLINE | ID: mdl-21833183

ABSTRACT

Propranolol is a widely used, non-selective ß-adrenergic receptor antagonist with proven efficacy in treating cardiovascular disorders and in the prevention of migraine headaches. At plasma concentrations exceeding those required for ß-adrenergic receptor inhibition, propranolol also exhibits anti-arrhythmic ("membrane stabilizing") effects that are not fully explained by ß-blockade. Previous in vitro studies suggested that propranolol may have local anesthetic effects. We directly tested the effects of propranolol on heterologously expressed recombinant human cardiac (NaV1.5) and brain (NaV1.1, NaV1.2, NaV1.3) sodium channels using whole-cell patch-clamp recording. We found that block was not stereospecific as we observed approximately equal IC50 values for tonic and use-dependent block by R-(+) and S-(-) propranolol (tonic block: R: 21.4 µM vs S: 23.6 µM; use-dependent block: R: 2.7 µM vs S: 2.6 µM). Metoprolol and nadolol did not block NaV1.5 indicating that sodium channel block is not a class effect of ß-blockers. The biophysical effects of R-(+)-propranolol on NaV1.5 and NaV1.1 resembled that of the prototypical local anesthetic lidocaine including the requirement for a critical phenylalanine residue (F1760 in NaV1.5) in the domain 4 S6 segment. Finally, we observed that brain sodium channels exhibited less sensitivity to R-(+)-propranolol than NaV1.5 channels. Our findings establish sodium channels as targets for propranolol and may help explain some beneficial effects of the drug in treating cardiac arrhythmias, and may explain certain adverse central nervous system effects.

15.
J Am Soc Nephrol ; 20(12): 2556-69, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19939939

ABSTRACT

Loss of polycystin-2 (PC2) in mice (Pkd2(-/-)) results in total body edema, focal hemorrhage, structural cardiac defects, abnormal left-right axis, hepatorenal and pancreatic cysts, and embryonic lethality. The molecular mechanisms by which loss of PC2 leads to these phenotypes remain unknown. We generated a model to allow targeted Pkd2 inactivation using the Cre-loxP system. Global inactivation of Pkd2 produced a phenotype identical to Pkd2(-/-) mice with undetectable PC2 protein and perinatal lethality. Using various Cre mouse lines, we found that kidney, pancreas, or time-specific deletion of Pkd2 led to cyst formation. In addition, we developed an immortalized renal collecting duct cell line with inactive Pkd2; these cells had aberrant cell-cell contact, ciliogenesis, and tubulomorphogenesis. They also significantly upregulated beta-catenin, axin2, and cMyc. Our results suggest that loss of PC2 disrupts normal behavior of renal epithelial cells through dysregulation of beta-catenin-dependent signaling, revealing a potential role for this signaling pathway in PC2-associated ADPKD.


Subject(s)
Mutation , Polycystic Kidney, Autosomal Dominant/genetics , TRPP Cation Channels/genetics , beta Catenin/metabolism , Animals , Apoptosis , Cell Line , Cell Proliferation , Cysts/genetics , Cysts/pathology , Disease Models, Animal , Female , Kidney Tubules, Collecting/abnormalities , Kidney Tubules, Collecting/metabolism , Kidney Tubules, Collecting/pathology , Liver Diseases/genetics , Liver Diseases/pathology , Male , Mice , Mice, Congenic , Mice, Inbred C57BL , Mice, Knockout , Pancreatic Diseases/genetics , Pancreatic Diseases/pathology , Phenotype , Polycystic Kidney, Autosomal Dominant/etiology , Polycystic Kidney, Autosomal Dominant/metabolism , Polycystic Kidney, Autosomal Dominant/pathology , Pregnancy , Signal Transduction , TRPP Cation Channels/deficiency , TRPP Cation Channels/metabolism , Up-Regulation
16.
Circ Arrhythm Electrophysiol ; 1(5): 370-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19808432

ABSTRACT

BACKGROUND: Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity. METHODS AND RESULTS: Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by approximately 10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block ( approximately 5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant. CONCLUSIONS: Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.


Subject(s)
Long QT Syndrome/genetics , Muscle Proteins/genetics , Mutation, Missense , Myocardium/metabolism , Sodium Channels/genetics , Sodium/metabolism , Action Potentials , Anti-Arrhythmia Agents/therapeutic use , DNA Mutational Analysis , Dose-Response Relationship, Drug , Drug Therapy, Combination , Electrocardiography , Genetic Predisposition to Disease , Gestational Age , Humans , Infant, Newborn , Kinetics , Long QT Syndrome/drug therapy , Long QT Syndrome/embryology , Long QT Syndrome/metabolism , Male , Mexiletine/therapeutic use , Muscle Proteins/antagonists & inhibitors , Muscle Proteins/metabolism , NAV1.5 Voltage-Gated Sodium Channel , Phenotype , Propranolol/therapeutic use , Recombinant Proteins/metabolism , Severity of Illness Index , Sodium Channel Blockers/therapeutic use , Sodium Channels/metabolism , Treatment Outcome
17.
Circ Res ; 102(3): 364-71, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18048769

ABSTRACT

Mutations in SCN5A encoding the principal Na+ channel alpha-subunit expressed in human heart (Na(V)1.5) have recently been linked to an inherited form of dilated cardiomyopathy with atrial and ventricular arrhythmia. We compared the biophysical properties of 2 novel Na(V)1.5 mutations associated with this syndrome (D2/S4--R814W; D4/S3--D1595H) with the wild-type (WT) channel using heterologous expression in cultured tsA201 cells and whole-cell patch-clamp recording. Expression levels were similar among WT and mutant channels, and neither mutation affected persistent sodium current. R814W channels exhibited prominent and novel defects in the kinetics and voltage dependence of activation characterized by slower rise times and a hyperpolarized conductance-voltage relationship resulting in an increased "window current." This mutant also displayed enhanced slow inactivation and greater use-dependent reduction in peak current at fast pulsing frequencies. By contrast, D1595H channels exhibited impaired fast inactivation characterized by slower entry into the inactivated state and a hyperpolarized steady-state inactivation curve. Our findings illustrate the divergent biophysical defects caused by 2 different SCN5A mutations associated with familial dilated cardiomyopathy. Retrospective review of the published clinical data suggested that cardiomyopathy was not common in the family with D1595H, but rather sinus bradycardia was the predominant clinical finding. However, for R814W, we speculate that an increased window current coupled with enhanced slow inactivation and rate-dependent loss of channel availability provided a unique substrate predisposing myocytes to disordered Na+ and Ca2+ homeostasis leading to myocardial dysfunction.


Subject(s)
Amino Acid Substitution , Arrhythmias, Cardiac/metabolism , Cardiomyopathy, Dilated/metabolism , Genetic Diseases, Inborn/metabolism , Muscle Proteins/metabolism , Mutation, Missense , Sodium Channels/metabolism , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/pathology , Calcium/metabolism , Cardiomyopathy, Dilated/genetics , Cardiomyopathy, Dilated/pathology , Cell Line , Genetic Diseases, Inborn/genetics , Genetic Diseases, Inborn/pathology , Homeostasis/genetics , Humans , Ion Transport/genetics , Muscle Proteins/genetics , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , NAV1.5 Voltage-Gated Sodium Channel , Patch-Clamp Techniques , Sodium/metabolism , Sodium Channels/genetics
18.
Circulation ; 115(3): 361-7, 2007 Jan 23.
Article in English | MEDLINE | ID: mdl-17210839

ABSTRACT

BACKGROUND: The hypothesis that some cases of sudden infant death syndrome (SIDS) could be caused by long-QT syndrome (LQTS) has been supported by molecular studies. However, there are inadequate data regarding the true prevalence of mutations in arrhythmia-susceptibility genes among SIDS cases. Given the importance and potential implications of these observations, we performed a study to more accurately quantify the contribution to SIDS of LQTS gene mutations and rare variants. METHODS AND RESULTS: Molecular screening of 7 genes (KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2, CAV3) associated with LQTS was performed with denaturing high-performance liquid chromatography and nucleotide sequencing of genomic DNA from 201 cases diagnosed as SIDS according to the Nordic Criteria, and from 182 infant and adult controls. All SIDS and control cases originated from the same regions in Norway. Genetic analysis was blinded to diagnosis. Mutations and rare variants were found in 26 of 201 cases (12.9%). On the basis of their functional effect, however, we considered 8 mutations and 7 rare variants found in 19 of 201 cases as likely contributors to sudden death (9.5%; 95% CI, 5.8 to 14.4%). CONCLUSIONS: We demonstrated that 9.5% of cases diagnosed as SIDS carry functionally significant genetic variants in LQTS genes. The present study demonstrates that sudden arrhythmic death is an important contributor to SIDS. As these variants likely modify ventricular repolarization and QT interval duration, our results support the debated concept that an ECG would probably identify most infants at risk for sudden death due to LQTS either in infancy or later on in life.


Subject(s)
Electrocardiography , Genetic Variation , Long QT Syndrome/complications , Long QT Syndrome/genetics , Sudden Infant Death/etiology , Sudden Infant Death/genetics , Adult , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/genetics , Case-Control Studies , Caveolin 3/genetics , Child, Preschool , Female , Genetic Testing/methods , Humans , Infant , Long QT Syndrome/diagnosis , Male , Middle Aged , Muscle Proteins/genetics , Mutation/genetics , NAV1.5 Voltage-Gated Sodium Channel , Norway , Potassium Channels/genetics , Risk Factors , Single-Blind Method , Sodium Channels/genetics
19.
Circulation ; 115(3): 368-76, 2007 Jan 23.
Article in English | MEDLINE | ID: mdl-17210841

ABSTRACT

BACKGROUND: Mutations in genes responsible for the congenital long-QT syndrome, especially SCN5A, have been identified in some cases of sudden infant death syndrome. In a large-scale collaborative genetic screen, several SCN5A variants were identified in a Norwegian sudden infant death syndrome cohort (n=201). We present functional characterization of 7 missense variants (S216L, R680H, T1304M, F1486L, V1951L, F2004L, and P2006A) and 1 in-frame deletion allele (delAL586-587) identified by these efforts. METHODS AND RESULTS: Whole-cell sodium currents were measured in tsA201 cells transiently transfected with recombinant wild-type or mutant SCN5A cDNA (hH1) coexpressed with the human beta1 subunit. All variants exhibited defects in the kinetics and voltage dependence of inactivation. Five variants (S216L, T1304M, F1486L, F2004L, and P2006A) exhibited significantly increased persistent sodium currents (range, 0.5% to 1.7% of peak current) typical of SCN5A mutations associated with long-QT syndrome. These same 5 variants also displayed significant depolarizing shifts in voltage dependence of inactivation (range, 5 to 14 mV) and faster recovery from inactivation, but F1486L uniquely exhibits a depolarizing shift in the conductance-voltage relationship. Three alleles (delAL586-587, R680H, and V1951L) exhibited increased persistent current only under conditions of internal acidosis (R680H) or when expressed in the context of a common splice variant (delQ1077), indicating that they have a latent dysfunctional phenotype. CONCLUSIONS: Our present results greatly expand the spectrum of functionally characterized SCN5A variants associated with sudden infant death syndrome and provide further biophysical correlates of arrhythmia susceptibility in this syndrome.


Subject(s)
Electrocardiography , Long QT Syndrome/complications , Long QT Syndrome/genetics , Muscle Proteins/genetics , Muscle Proteins/physiology , Mutation, Missense/genetics , Sodium Channels/genetics , Sodium Channels/physiology , Sudden Infant Death/etiology , Sudden Infant Death/genetics , Alleles , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/physiopathology , Cohort Studies , DNA, Complementary/genetics , Electrophysiology , Gene Expression Regulation , Genetic Predisposition to Disease , Genetic Testing/methods , Genetic Variation/genetics , Humans , Infant , Long QT Syndrome/physiopathology , Mathematics , NAV1.5 Voltage-Gated Sodium Channel , Norway , Phenotype , Risk Factors
20.
Epilepsia ; 47(10): 1636-42, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17054685

ABSTRACT

PURPOSE: Mutations in SCN1A, encoding the human Na(V)1.1 neuronal voltage-gated sodium channel, cause the syndrome of severe myoclonic epilepsy of infancy (SMEI). Most SMEI-associated mutations are predicted to truncate the SCN1A protein, likely causing a loss of sodium channel function. However, many missense or in-frame deletion SCN1A mutations have also been reported in this disorder, but their functional impact is largely unknown. Here we report the functional characterization of eight SCN1A mutations (G177E, I227S, R393H, Y426N, H939Q, C959R, delF1289, and T1909I) previously identified in SMEI probands. METHODS: SCN1A mutants were constructed in a recombinant human SCN1A and then heterologously expressed in human tsA201 cells along with the human beta(1) and beta(2) sodium channel accessory subunits. Whole-cell patch-clamp recording was used to define biophysical properties of each mutant and for comparison with the wild-type (WT) channel. RESULTS: Six of the mutants were nonfunctional, but Y426N and T1909I generated measurable sodium channel activity. Cells expressing Y426N and T1909I had significantly lower current densities compared with WT-SCN1A. In addition, other biophysical abnormalities were observed for the two functional mutants including decreased channel availability (Y426N) and increased persistent sodium current (T1909I). CONCLUSIONS: We conclude that SMEI is caused either by complete loss of SCN1A function, or by dysfunctional sodium channels exhibiting mixed biophysical properties. This wide spectrum of functional defects observed among SCN1A mutations suggests that SMEI may result from more than a single molecular or cellular mechanism, or require other factors for pathogenesis.


Subject(s)
Epilepsies, Myoclonic/genetics , Mutation/genetics , Nerve Tissue Proteins/genetics , Sodium Channels/genetics , Epilepsies, Myoclonic/physiopathology , Gene Expression/genetics , Humans , Membrane Potentials/genetics , Membrane Potentials/physiology , Mutation, Missense/genetics , NAV1.1 Voltage-Gated Sodium Channel , Patch-Clamp Techniques , Phenotype , Sodium Channels/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...